Last week, the House of Representatives passed three bills containing provisions that would require certain of the financial regulatory agencies to conduct cost-benefit analysis as part of the rulemaking process: the Regulatory Accountability Act of 2017 (H.R. 5), the SEC Regulatory Accountability Act (H.R. 78), and the Commodity End-User Relief Act (H.R. 238).  The scope and cost-benefit analysis standards of each bill vary, and thus we have prepared these slides to compare the three proposals in active consideration, as well as two previous bill proposals that remain relevant and contain similar provisions.

Law clerk Conrad Scott contributed to this post.